Scott Sherrill-Mix

6PUBLICATIONS
92CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Nanotoxicology, health and safetyVirologyInnate immunityGenome structure and regulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 13, 2024
TET2 regulates early and late transitions in exhausted CD8+ T cell differentiation and limits CAR T cell function.

Alexander J Dimitri, Amy E Baxter, Gregory M Chen

|Dec 31, 2021
A Summary of the Sixth International Workshop on Microbiome in HIV Pathogenesis, Prevention, and Treatment.

Scott Sherrill-Mix, Michelle Yang, Grace M Aldrovandi

|Oct 20, 2021
DNA binding to TLR9 expressed by red blood cells promotes innate immune activation and anemia.

L K Metthew Lam, Sophia Murphy, Dimitra Kokkinaki

|Mar 27, 2021
CD4 receptor diversity represents an ancient protection mechanism against primate lentiviruses.

Ronnie M Russell, Frederic Bibollet-Ruche, Weimin Liu

|Jan 14, 2021
Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption.

Marcos V P Gondim, Scott Sherrill-Mix, Frederic Bibollet-Ruche

|May 15, 2020
Single-cell transcriptional landscapes reveal HIV-1-driven aberrant host gene transcription as a potential therapeutic target.

Runxia Liu, Yang-Hui Jimmy Yeh, Ales Varabyou

Pageof 1